ADXN Stock Analysis: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$6.10
0.06 (0.99%)
▲
5d:
-3.94%
30d:
-13.72%
90d:
-22.78%
BUY
HIGH Confidence
Analysis Updated: Apr 7, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ADXN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ADXN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $6.10, which is considered slightly low relative to its 30-day fair value range of $6.00 to $7.04.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $5.63, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+391.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $5.63, while resistance sits at $7.15.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+391.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.00 -
$7.04
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 391.8% below Wall St target ($30.00)
Fair Price Analysis
30-Day Fair Range
$6.00 -
$7.04
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.64
Resistance Level
$7.15
Current Trend
Strong Downtrend
Technical data as of
Apr 7, 2026
Fundamental Context
Wall Street Target
$30.00
(+391.8%)
Revenue Growth (YoY)
-15.0%
Share & Embed Analysis
Last updated: April 07, 2026 9:55 PM ET
Data refreshes hourly during market hours. Next update: 10:55 PM
Data refreshes hourly during market hours. Next update: 10:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 62 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
